resorcinol has been researched along with Lymphoma, T-Cell in 1 studies
resorcinol: RN given refers to parent cpd; structure in Merck Index, 9th ed, #7951
resorcinol : A benzenediol that is benzene dihydroxylated at positions 1 and 3.
Lymphoma, T-Cell: A group of heterogeneous lymphoid tumors representing malignant transformations of T-lymphocytes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| López, P | 1 |
| Ferraro, G | 1 |
| Anesini, C | 1 |
1 other study available for resorcinol and Lymphoma, T-Cell
| Article | Year |
|---|---|
Comparative antioxidant activity of an extract of Lithraea molleoides and an isolated 5-alkyl resorcinol derivative. Effects on the proliferation of normal and tumoral lymphocytes.
Topics: Anacardiaceae; Animals; Cell Line, Tumor; Cell Proliferation; Chromatography, High Pressure Liquid; | 2011 |